Corticosteroid Resistance and Novel Anti-Inflammatory Therapies in Chronic Obstructive Pulmonary Disease

  title={Corticosteroid Resistance and Novel Anti-Inflammatory Therapies in Chronic Obstructive Pulmonary Disease},
  author={Amir Hakim and Ian M. Adcock and PhD FHEA FRCP Dr Omar S. Usmani MBBS},
Corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, in contrast to their use in mild-to-moderate asthma, they are much less effective in enhancing lung function and have little or no effect on controlling the underlying chronic inflammation. In most clinical trials in COPD patients, corticosteroids have shown little benefit as monotherapy, but have shown a greater clinical effect in combination with long-acting bronchodilators. Several… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 16 extracted citations

Jinwei Tang modulates HDAC2 expression in a rat model of COPD.

Experimental and therapeutic medicine • 2018


Publications referenced by this paper.
Showing 1-10 of 103 references

New therapies for chronic obstructive pulmonary disease.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre • 2010
View 3 Excerpts
Highly Influenced

Beyond corticosteroids: future prospects in the management of inflammation in COPD.

European respiratory review : an official journal of the European Respiratory Society • 2011
View 1 Excerpt

Current controversies and future perspectives in chronic obstructive pulmonary disease.

American journal of respiratory and critical care medicine • 2011
View 1 Excerpt

Similar Papers

Loading similar papers…